The Senate Finance Committee voted along party lines to send Kennedy’s bid to lead the Department of Health and Human ...

All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FDA advisors largely supported the regulatory approval of condoliase for nerve pain associated with lumbar disc ...

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...

Nuplazid (pimavanserin) is already FDA-approved to treat psychosis caused by Parkinson's disease, but Acadia's hope to expanding that use to the Alzheimer's population were shot down by a complete ...

The proposals would see alcohol labeling come closer to that for non-alcoholic beverages: with serving sizes, calorie counts, ...